N-[2-[2-hydroxy-4-(methanesulfonamido) -5-phenoxyphenyl]-2-oxoethyl]fommaide CAS 149457-03-4

 

Pwodwi Deskripsyon:

Non pwodwi: N-[2-[2-hydroxy-4-(methanesulfonamido)-5-phenoxyphenyl]-2-oxoethyl]fommaide CAS NON: 149457-03-4

 

Sinonim:

Methanesulfonamide, N-[4-[2-(fomylamino)-5-5-hydroxy-2-phenoxyphenyl]-;

 

Chimik & Pwopriyete fizik:

Aparans: blan koupe-blan Powder

Assay: ≥99.0%

Dansite: 1.4g/cm3

Bouyi pwen: 622.4 ° C nan 760 mmHg

Flash Pwen: 330.2 ° C

Endeks refraksyon:1.628

Dlo Solibilite: Tre yon ti kras solib (0.11 g / L) (25 ºC)

 

Entemedye Iguratimod.

Iguratimod se yon nouvo kalite dwog pou tretman atrit rimatoyid (RA) ak osteyoartritis (OA) devlope pa konpayi Toyama Japon an. Japon aplike pou maketing nan 2003.

 

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.

 

 

 

Baj popilè: N-[2-[2-hydroxy-4-(methanesulfonamido) -5-phenoxyphenyl]-2-oxoethyl]fomelide cas 149457-03-4, manifaktire, founise, faktori, achte, nan stock

• On: N, N-Dimethylformide Dimethylformide D' CAS 4637-24-5
• Pwochen: Ganciclovir CAS 82410-32-0